173 related articles for article (PubMed ID: 6884709)
1. Impaired natural killer cell activity in patients with inflammatory bowel disease: evidence for a qualitative defect.
Ginsburg CH; Dambrauskas JT; Ault KA; Falchuk ZM
Gastroenterology; 1983 Oct; 85(4):846-51. PubMed ID: 6884709
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cell activity in patients with inflammatory bowel disease.
Egawa S; Hiwatashi N
J Clin Lab Immunol; 1986 Aug; 20(4):187-92. PubMed ID: 3093683
[TBL] [Abstract][Full Text] [Related]
3. Immune status in Crohn's disease. V. Decreased in vitro natural killer cell activity in peripheral blood.
Auer IO; Ziemer E; Sommer H
Clin Exp Immunol; 1980 Oct; 42(1):41-9. PubMed ID: 7460390
[TBL] [Abstract][Full Text] [Related]
4. In vitro cellular cytotoxicity in Crohn's disease and ulcerative colitis: relation with disease activity and treatment, and the effect of recombinant gamma-interferon.
Aparició-Pagés MN; Verspaget HW; Peña AS; Weterman IT; de Bruin PA; Mieremet-Ooms MA; van der Zon JM; van Tol EA; Lamers CB
J Clin Lab Immunol; 1989 Jul; 29(3):119-24. PubMed ID: 2517428
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal B lymphocytes in the peripheral blood of patients with inflammatory bowel disease.
Ginsburg CH; Ault KA; Falchuk ZM
Gastroenterology; 1981 Dec; 81(6):1111-4. PubMed ID: 7026345
[TBL] [Abstract][Full Text] [Related]
6. Natural, lectin- and phorbol ester-induced cellular cytotoxicity in Crohn's disease and ulcerative colitis.
Aparicio-Pagés MN; Verspaget HW; Peña AS; Weterman IT; Mieremet-Ooms MA; van der Zon JM; de Bruin PA; Lamers CB
J Clin Lab Immunol; 1988 Nov; 27(3):109-13. PubMed ID: 3246686
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cell function and lymphocyte subpopulation profiles in inflammatory bowel disease.
Brown TE; Bankhurst AD; Strickland RG
J Clin Lab Immunol; 1983 Jul; 11(3):113-7. PubMed ID: 6224936
[TBL] [Abstract][Full Text] [Related]
8. In vitro testing of immunoresponsiveness in patients with inflammatory bowel disease: prevalence and relationship to disease activity immunoresponsiveness in IBD.
Lyanga JJ; Davis P; Thomson AB
Clin Exp Immunol; 1979 Jul; 37(1):120-5. PubMed ID: 314871
[TBL] [Abstract][Full Text] [Related]
9. Immunological studies on Crohn's disease. III. Defective natural killer activity.
Okabe N; Fujita K; Yao T
J Clin Lab Immunol; 1985 Jul; 17(3):143-6. PubMed ID: 4046002
[TBL] [Abstract][Full Text] [Related]
10. Alteration in T lymphocyte subpopulations in inflammatory bowel disease.
Victorino RM; Hodgson HJ
Clin Exp Immunol; 1980 Jul; 41(1):156-65. PubMed ID: 6969150
[TBL] [Abstract][Full Text] [Related]
11. Distal procto-colitis, natural cytotoxicity, and essential fatty acids.
Almallah YZ; Richardson S; O'Hanrahan T; Mowat NA; Brunt PW; Sinclair TS; Ewen S; Heys SD; Eremin O
Am J Gastroenterol; 1998 May; 93(5):804-9. PubMed ID: 9625132
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin M memory B cell decrease in inflammatory bowel disease.
Di Sabatino A; Carsetti R; Rosado MM; Ciccocioppo R; Cazzola P; Morera R; Tinozzi FP; Tinozzi S; Corazza GR
Eur Rev Med Pharmacol Sci; 2004; 8(5):199-203. PubMed ID: 15638230
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood mononuclear cells from patients with inflammatory bowel disease exhibit normal function in the allogeneic and autologous mixed leukocyte reaction and cell-mediated lympholysis.
MacDermott RP; Bragdon MJ; Thurmond RD
Gastroenterology; 1984 Mar; 86(3):476-84. PubMed ID: 6229444
[TBL] [Abstract][Full Text] [Related]
14. Defective autologous mixed-lymphocyte reaction and suppressor cell generation in patients with inflammatory bowel disease.
Ginsburg CH; Falchuk ZM
Gastroenterology; 1982 Jul; 83(1 Pt 1):1-9. PubMed ID: 6210596
[TBL] [Abstract][Full Text] [Related]
15. [Natural killer cells in inflammatory diseases of the large intestine].
Khalif IL; Bakhov NI; Kirkin BV; Osipov SG; Mikhaĭlova TL
Sov Med; 1986; (4):32-4. PubMed ID: 3715605
[No Abstract] [Full Text] [Related]
16. Impaired cell-mediated immunity in hemophilia. II. Persistence of subclinical immunodeficiency and enhancement of natural killer activity by lymphokines.
Lederman MM; Ratnoff OD; Schacter B; Shoger T
J Lab Clin Med; 1985 Aug; 106(2):197-204. PubMed ID: 2410523
[TBL] [Abstract][Full Text] [Related]
17. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.
Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; Lémann M; Mayer L; Toubert A
Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210
[TBL] [Abstract][Full Text] [Related]
18. [Natural killer (NK) cells and interleukin 2 (IL-2) in Crohn disease].
Lozano Polo JL; Echevarría Vierna S; Casafont Morencos F; Ledesma Castaño F; Pons Romero F
Rev Esp Enferm Dig; 1990 Aug; 78(2):71-5. PubMed ID: 2271297
[TBL] [Abstract][Full Text] [Related]
19. Elevated numbers of peripheral T cells in inflammatory bowel diseases displaying T9 antigen and Fc alpha receptors.
Raedler A; Fraenkel S; Klose G; Thiele HG
Clin Exp Immunol; 1985 Jun; 60(3):518-24. PubMed ID: 2990780
[TBL] [Abstract][Full Text] [Related]
20. Alteration of natural killer cell subsets (two color analysis) and their activity in peripheral blood in inflammatory bowel disease.
Hirata I; Hayashi K; Asada S; Miyoshi H; Iwakoshi K; Ohshiba S
Bull Osaka Med Coll; 1990 Nov; 36(1-2):47-55. PubMed ID: 2135644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
